gershon
GLP-1 Apprentice

original research here..... just a matter of time before it starts showing up I suppose....
NK2R control of energy expenditure and feeding to treat metabolic diseases - Nature
In mouse and nonhuman primate models, treatment with selective, long-acting neurokinin 2 receptor agonists aids weight loss by suppressing appetite and increasing energy expenditure, as well as by increasing insulin sensitivity.
www.nature.com
NK2R control of energy expenditure and feeding to treat metabolic diseases - Nature
In mouse and nonhuman primate models, treatment with selective, long-acting neurokinin 2 receptor agonists aids weight loss by suppressing appetite and increasing energy expenditure, as well as by increasing insulin sensitivity.
www.nature.com
